Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men

Atherosclerosis

Volumn 157, Issue 2, 2001, Pages 495-503

  Chu, Nain Feng ^a,d   Spiegelman, Donna ^a   Hotamisligil, Gökhan S ^a   Rifai, Nader ^b   Stampfer, Meir ^a,c   Rimm, Eric B ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular disease; Insulin; Leptin; Risk factors; TNF

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 7; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATHEROGENESIS; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; HOMEOSTASIS; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SMOKING; THROMBOGENESIS;

ADULT; AGED; ARTERIOSCLEROSIS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; SOLUBILITY; THROMBOSIS;

EID: 0034907012     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00755-3     Document Type: Article

References (45)

1. Obesity, lipids, and glucose intolerance. The Framingham Study
2. Epidemiology of obesity in relation to health hazards
3. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men
4. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men
5. Relationship to weight change in atherogenic traits: The Framingham study
6. Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis
7. Banting lecture 1988. Role of insulin resistance in human disease
8. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study
9. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance
10. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study, 15-year follow-up
11. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease
12. Hyperinsulinemia as an independent risk factor for ischemic heart disease
13. Insulin in ischaemic heart disease: Are associations explained by triglyceride concentrations? The Caerphilly prospective study
14. Is insulin really a heart disease risk factor
15. Positional cloning of the mouse obese gene and its human homologue
16. The ob gene and insulin. A relationship leading to clues to the understanding of obesity
17. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: Cross sectional study
18. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
19. Modulation of insulin activities by leptin
20. Leptin concentrations and insulin sensitivity in normoglycemic men
21. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk
22. The tumor necrosis factor ligand and receptor families
23. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes
24. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance
25. Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans
26. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity
27. Cardiovascular consequences of obesity: Role of leptin
28. Tumor necrosis factor alpha: A key component of the obesity-diabetes link
29. Validity of self-reported waist and hip circumferences in men and women
30. The assessment of alcohol consumption by a simple self-administered questionnaire
31. Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals
32. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals
33. Stability of human plasma leptin concentrations with 36 hours following specimen collection
34. Radioimmunoassay of leptin in human plasma
35. Analytical and clinical performance of a homogenous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate Mg + + method
36. A rapid physiological coagulation method in determination of fibrinogen
37. Maximum likelihood estimation of misspecified models
38. Biochemical indicators of dietary intake
39. Leptin and other secretory products of adipocytes modulate multiple physiological functions
40. The molecular link between obesity and diabetes
41. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study
42. Plasma leptin concentrations: Gender differences and associations with metabolic risk factors for cardiovascular disease
43. Circulating leptin concentrations in polycystic ovary syndrome: Relation to anthropometric and metabolic parameters
44. Concurrent reductions of serum leptin and lipids during weight loss in obese men with type II diabetes
45. Direct antidiabetic effect of leptin through triglyceride depletion of tissues